No replacement for Enhance Group’s ex-Singapore MD; BNPP AM names new Hong Kong CEO; T Rowe makes two senior appointments in Japan; GAM launches healthcare equity fund in Taiwan; Fidelity’s Eight Roads rolls out China-focused healthcare fund; BNPP AM acquires majority stake in Belgian robo-advisory firm; and more
FSA compares the Fidelity China Focus Fund and the UBS China Opportunity Fund.
FSA compares two Asean equity funds: the Fidelity Asean Fund and the JP Morgan Asean Fund.
Asset managers comment on Moody’s decision to lower China’s sovereign credit rating by one notch to A1 from Aa3, with stable outlook.
Chinese government bond yields have surged due to regulatory actions, presenting a buying opportunity, according to several fund managers.
The recent oil price retreat is just noise, and large cap energy company valuations are at historical lows, according to Toby Gibb, Fidelity International’s investment director of European equities.
Fidelity International has announced the launch of its China Bond No.1 Private Fund, the first ever fund product launched by a foreign firm in China.
AXA IM launches a multi-premia fund; ETFs in the US continue to grow; Fidelity rolls out a digital campaign; Singapore’s 8 Capital received fund licence; Pictet AM poaches from Invesco; SFC re-appoints Ashley Alder as CEO; and others
Fidelity analyst sentiment toward Chinese companies has turned to warm from cool in 2017, buoyed by strong balance sheets, according to the firm’s 2017 analyst survey.
FSA compares the Fidelity Emerging Asia Fund with the Schroder ISF Emerging Asia Fund.
Part of the Mark Allen Group.
